Bramhall M, Flórez-Vargas O, Stevens R, Brass A, Cruickshank S. Quality of methods reporting in animal models of colitis. Inflammatory Bowel Diseases 2015, 21; 1248–1259
Denes A, Coutts G, Lénárt N, Cruickshank SM, Pelegrin P, Skinner J, Rothwell N, Allan SM, Brough D. AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3 Proceedings of the National Academy of Sciences of the USA 2015 112 (13): 4050–4055
Bowcutt R, Bramhall M, Logunova L. Wilson J, Booth C, Carding SR, Grencis RK, Cruickshank SM. A role for the pattern recognition receptor Nod2 in mediating recruitment of CD103+ dendritic cells to the colon in response to infection. Mucosal Immunol 2014 7(5):1094-105.
Campbell L, Williams H, Crompton R, Cruickshank SM, M Hardman. Nod2 deficiency impairs inflammatory and epithelial aspects of the cutaneous wound healing response. J Pathol 2013 229: 121–131.
Dalton JE, Cruickshank SM, Egan CE, Mears L, Newton DJ, Lawrence B, English N, White S, Howell G, Else KJ, Gubbels M, Striepen B, Smith J and SR. Carding. A subset of TCRgd+ intraepithelial lymphocytes are required to maintain epithelial tight junction integrity and intestinal barrier function. 2006 Gastroenterology
Ashcroft AJ, Cruickshank S, Croucher PI, Perry MJ, Rollinson SJ, Lippitt JM, Child JA, Dunstan C, Morgan GJ, Carding SR. Colonic Dendritic Cells, colitis and T cell-mediated bone destruction are modulated by recombinant Osteoprotegerin. Immunity. 2003 19: 849-861